Tesis Biosciences, the leader in targeted genetic sequencing, and Genome Explorations, Tesis’ clinical research and development division, have announced a proposed study designed to develop molecular biomarkers to differentiate mild traumatic brain injury (mTBI) from posttraumatic stress disorder (PTSD).
Read more about this exciting proposed study via the full press release here.
Genome Explorations, A Tesis Biosciences Company, is an industry leader in providing a complete range of Molecular Diagnostics (MDx) Services to clinical institutes worldwide.
